IPHA

IPHA

USD

Innate Pharma S.A. ADS

$1.840-0.040 (-2.128%)

Precio en Tiempo Real

Healthcare
Biotecnología
Francia

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.880

Máximo

$1.880

Mínimo

$1.840

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

172.7M

Industria

Biotecnología

País

France

Estadísticas de Negociación

Volumen Promedio

0.02M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $1.29Actual $1.840Máximo $3.511

Noticias Relacionadas

BusinessWire

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an

Ver más
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Analyst Upgrades

HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Innate Pharma from Neutral to Buy and announces $5 price target.

Ver más
HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target

BTIG analyst Justin Zelin reiterates Innate Pharma with a Buy and maintains $8 price target.

Ver más
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.